Northwest Georgia Oncology Centers

What Northwest Georgia Oncology Centers does

Northwest Georgia Oncology Centers, P.C. (NGOC) is a physician-owned, private professional corporation operating a network of 15 community-based cancer centers across 9 counties in northwest Georgia and east Alabama. Founded in 1995 by Carlos A. Osmon, MD and Bruce J. Gould, MD, the practice is led by Madhurima Uppalapati, MD as President and Medical Director. NGOC delivers medical oncology and hematology services through a team of 21 physicians—many fellowship-trained at MD Anderson, Johns Hopkins, Duke, or Emory—supported by physician assistants and oncology nurses. Treatment modalities include chemotherapy, hormonal therapy, immunotherapy, targeted therapy, and coordinated radiation therapy, alongside second-opinion consultations and telemedicine visits delivered via Doxy.me.

The practice is anchored by the William S. Gibbons Cancer Research Institute, which is registered with the National Cancer Institute and serves as the platform for NGOC's Phase I–IV clinical trial program; reported participation rates exceed national averages. NGOC operates as a community oncology network rather than an academic medical center, distributing care through co-branded facilities inside Wellstar Health System (Kennestone, Cobb, Douglas, Paulding, North Fulton, plus Cartersville and Spalding Medical Center) and Tanner Health System (Carrollton, Bremen, Villa Rica, and Tanner Medical Center/East Alabama). Patient-facing digital infrastructure consists of dual MyChart integrations with Wellstar and Tanner, online referral workflows for physician offices, and a central referral line.

The revenue model is fee-for-service medical oncology billed to Medicare, Medicaid, and commercial insurance, supplemented by clinical trial sponsor revenue (AstraZeneca, Bristol Myers Squibb, Roche/Genentech, Gilead, Boehringer Ingelheim, Daiichi Sankyo, AbbVie). Customer acquisition is primarily referral-led from primary care physicians and specialists across the 9-county service area, with co-marketing through hospital partners reinforcing top-of-funnel awareness. NGOC is HIPAA-compliant and adheres to federal Transparency in Coverage Rule machine-readable file requirements.

Name

Northwest Georgia Oncology Centers

Legal name

Northwest Georgia Oncology Centers, P.C.

Website

https://ngoc.com

Company type

Private

Founded year

1995

Operating status

Operating

Headcount range

11–50 employees

Short description

Northwest Georgia Oncology Centers is a physician-owned community oncology practice operating 15 cancer centers across 9 counties in Georgia and Alabama, serving cancer and hematology patients through chemotherapy, immunotherapy, targeted therapy, clinical trials, and telemedicine.

Ownership category

akta.pro rank

Product category

Oncology and Hematology Care Services

NAICS

Ambulatory Health Care Services (621), Other Outpatient Care Centers (62149)

SIC

Services-Offices & Clinics Of Doctors Of Medicine (8011), Services-Specialty Outpatient Facilities, Nec (8093)

akta.pro primary industry

Ambulatory Oncology Centers (Outpatient Chemo/Radiation) (HLAFABAI)

akta.pro secondary industries

Oncology Telemedicine Platforms (HLALAGAH), Medical Oncology (HLAKAFAB)

Keywords

• Medical oncology services
• Hematology treatment
• Cancer care centers
• Clinical trials oncology
• Chemotherapy services

Headquarters

HQ city

Marietta

HQ country

United States

HQ region

North America

Offices15 records

Markets served

GTM type

B2C

Offering type

Services

Cost components

Personnel, Operations, Technology or R&D, Marketing or Sales, Infrastructure

Revenue model

1. Medical Oncology Services: Fee-for-service medical care including chemotherapy, hormonal therapy, immunotherapy, targeted therapy, and related cancer treatments. Revenue generated through insurance billing (Medicare, Medicaid, commercial insurance) and patient payments.
2. Clinical Trial Services: Clinical trials provide access to experimental treatments while generating revenue through clinical research agreements and pharmaceutical company sponsorships. Participation rates often surpass national averages.

Pricing tiers

Go-to-market motion3 records

Distribution channels4 records

Marketing channels5 records

Core offering

NGOC delivers comprehensive medical oncology and hematology care across 15 community-based cancer centers in 9 counties of Georgia and Alabama. The core offering centers on chemotherapy, hormonal therapy, immunotherapy, targeted therapy, and radiation therapy, supported by an in-house clinical trials program (William S. Gibbons Cancer Research Institute) and complemented by telemedicine, second opinion consultations, and integrated hospital-based services through Wellstar and Tanner Health System partnerships.

Product overview

Northwest Georgia Oncology Centers (NGOC) is a community oncology practice operating as a unified network of 15 community-based cancer centers across 9 counties in Georgia and Alabama. The core offering centers on comprehensive medical oncology and hematology care, delivered through a coordinated team of 21+ physicians, physician assistants, and oncology nurses. The treatment portfolio includes chemotherapy, hormonal therapy, immunotherapy, targeted therapy, and radiation therapy — with each modality personalized to the patient's specific cancer type, stage, and characteristics. NGOC's treatment ecosystem is anchored by its own William S. Gibbons Cancer Research Institute, which runs a clinical trials program (spanning Phase I–IV trials) giving patients access to experimental drugs and cutting-edge research modalities not available at standard practices. The network also provides patient-facing digital services including telemedicine video visits (via Doxy.me), online patient portals (Wellstar MyChart and Tanner MyChart), and second opinion consultations. NGOC partners with Wellstar Health System and Tanner Health System to operate facilities under co-branded names (e.g., NGOC/Wellstar Kennestone Cancer Center, NGOC/Tanner Medical Center). The practice is led by President and Medical Director Dr. Madhurima Uppalapati and Chief Cancer Officer Dr. Michael B. Andrews.

Differentiator

Problem solved

Functional benefit

Products and services

• Chemotherapy Chemotherapy treatment for localized tumors limited to a specific area and metastatic cancers that have spread to other parts of the body, delivered by NGOC oncologists.
• Hormonal Therapy Hormonal therapy that removes, blocks, or adds hormones to destroy or slow the growth of cancer cells.
• Immunotherapy Biological therapy that helps the body fight infectious and other diseases, including cancer, by leveraging the immune system.
• Targeted Therapy Drug therapy that targets specific genes and proteins involved in the growth and survival of cancer cells, affecting the tissue environment related to cancer growth.
• Radiation Therapy Radiation therapy offered as part of the treatment modality options, working collaboratively with other treatment approaches.
• Clinical Trials Program (William S. Gibbons Cancer Research Institute) Scientific drug studies (Phase I-IV) conducted through NGOC's William S. Gibbons Cancer Research Institute, allowing patients access to experimental drugs and the latest research treatment modalities.
• Telemedicine / Video Visits Virtual video visit consultations via Doxy.me platform, enabling patients to connect with NGOC oncologists remotely for expanded access to care.
• Cancer Center Network (15 Community-Based Centers in 9 Counties) Network of 15 community-based cancer centers across 9 counties in Georgia and Alabama, providing localized treatment access in Austell, Cartersville, Douglasville, Cherokee, Spalding, Jasper, Paulding, North Fulton, Marietta, Vinings, West Georgia, Bremen, Carrollton, Villa Rica, and Wedowee, AL.
• Second Opinion Consultations Second opinion consultations providing patients with peace of mind and confidence in their cancer care, reviewing pathology reports, imaging, and previous treatment records.
• Patient Portal Access (Wellstar MyChart and Tanner MyChart) Online patient portals via Wellstar MyChart and Tanner MyChart enabling patients to access medical records, schedule appointments, view test results, and manage their cancer care.

Quantifiable outcome

• Clinical trial participation rates often surpass national averages
• +1 more outcomes

Named customers2 records

Segments3 records

Ideal customer profiles2 records

Technology focussed No

API detail

Has API

No

API docs

API detail

Core technology

AI maturity

App detail

Integration4 records

Feature2 records

Partnerships

Ten partnerships are on record, tiered minor and core.

• AstraZeneca (Artemide-Gastric01, ARTEMIDE-Biliary02)minorStrategic or Co-development Partner · 1 April 2026Clinical trial sponsorship for gastric cancer, biliary tract cancer, and lung cancer studies. NGOC serves as clinical trial site with principal investigators including Dr. Shaib participating in Phase III trials.
• Bristol Myers Squibb (MountainTAP-30, ROSETTA CRC-203, ROSETTA Lung-202, TIGOS)minorStrategic or Co-development Partner · 1 April 2026Clinical trial sponsorship for pancreatic cancer, colorectal cancer, lung cancer, and small cell lung cancer studies. NGOC participates as clinical trial site in Phase II/III studies.
• Roche/Genentech (INAVO123)minorStrategic or Co-development Partner · 1 April 2026Clinical trial sponsorship for breast cancer study evaluating inavolisib plus CDK4/6 inhibitor. NGOC serves as clinical trial site.
• Gilead (ASCENT-05)minorStrategic or Co-development Partner · 1 April 2026Clinical trial sponsorship for triple negative breast cancer study with sacituzumab govitecan. NGOC participates as clinical trial site.
• Boehringer Ingelheim (Beamion Lung-3)minorStrategic or Co-development Partner · 1 April 2026Clinical trial sponsorship for non-small cell lung cancer study with zongertinib. NGOC participates as clinical trial site.
• Daiichi Sankyo (TROPION-Lung17)minorStrategic or Co-development Partner · 1 April 2026Clinical trial sponsorship for TROP2-positive advanced NSCLC study with datopotamab deruxtecan. NGOC participates as clinical trial site.
• AbbVie (TELImet NSCLC-04)minorStrategic or Co-development Partner · 1 April 2026Clinical trial sponsorship for non-small cell lung cancer study with telisotuzumab vedotin. NGOC participates as clinical trial site.
• Wellstar Health SystemcoreStrategic or Co-development Partner · 1 February 2026Major healthcare system partnership providing hospital-based oncology services at Wellstar facilities including Kennestone Hospital (Marietta), Cobb Hospital (Austell), Douglas Hospital, Paulding Hospital, and North Fulton Hospital. New dedicated facilities opened at Cartersville and Spalding Medical Center locations.
• Tanner Health SystemcoreStrategic or Co-development Partner · 1 September 2024Partnership with Tanner Health System for cancer care services at facilities including Tanner Medical Center in Carrollton, Bremen, Villa Rica, and East Alabama (Wedowee). NGOC physicians provide oncology services at Tanner locations with shared patient portal (Tanner MyChart).
• Loving Arms Cancer OutreachminorGTM or Marketing Partner · 1 March 2024Non-profit cancer support organization founded by oncology nurses. NGOC proudly supports this organization which provides emotional support, financial assistance, transportation to treatments, support groups, and educational programs for cancer patients and families.

Scale indicators4 records

Recent moves9 records

Expansion highlights5 records

Direct peers

• Tennessee Oncology: Tennessee Oncology is one of the largest community-based oncology practices in the U.S., offering medical oncology, hematology, and clinical trials across multiple Tennessee locations. It mirrors NGOC's model of community cancer centers, hospital partnerships, and an in-house research institute, making it a highly comparable peer.
• Florida Cancer Specialists & Research Institute: Florida Cancer Specialists is the largest community oncology practice in the U.S., operating 100+ locations across Florida with an integrated clinical trials program. Comparable to NGOC in offering medical oncology, hematology, immunotherapy, and clinical research across a multi-county community footprint.
• OneOncology: OneOncology is a partnership platform of leading independent community oncology practices, providing practice management, technology, and clinical research infrastructure. It is a direct competitor and potential aggregator of practices like NGOC.
• The US Oncology Network (McKesson): The US Oncology Network is one of the largest networks of community-based oncology practices, now part of McKesson. Comparable to NGOC in supporting community oncology with clinical trials, technology, and practice management services across the U.S.
• Atlanta Cancer Care: Atlanta Cancer Care is a community oncology practice serving the Atlanta metro with medical oncology, hematology, and clinical trials. Directly overlaps NGOC's Georgia footprint and serves a comparable patient population.
• Astera Cancer Care: Astera Cancer Care is a community-based oncology and hematology practice serving New Jersey, Michigan, and Pennsylvania with medical oncology and clinical trials. Mirrors NGOC's model of multi-site community cancer centers integrated with hospital partners.
• Piedmont Cancer Institute: Piedmont Cancer Institute is a community oncology practice in the Atlanta metro offering medical oncology and hematology. It is a direct competitor for physician referrals and oncology patients across Georgia.
• Oncology Hematology Care (OHC): OHC is a community-based oncology and hematology practice serving the Cincinnati tri-state region. Comparable to NGOC in scale and model: multi-site community cancer centers with integrated clinical research and hospital partnerships.
• New England Cancer Specialists: New England Cancer Specialists is a multi-site community oncology and hematology practice offering chemotherapy, immunotherapy, and clinical trials in Maine. Comparable to NGOC as an independent physician-owned community oncology network with an in-house clinical research program.

Broad incumbents

• Winship Cancer Institute of Emory University: Winship is the NCI-designated Comprehensive Cancer Center serving the Atlanta metro and Georgia. It represents the academic-tier competitive set that NGOC competes against for complex oncology referrals and clinical trial patients within the same geography.

Market position

Weaknesses5 records

Competitive moat5 records

Key risks6 records

Key highlights7 records

Customer concentration

• LinkedInlinkedin.com/company/northwest-georgia-oncology-center

Compliance4 records

Revenue estimate

Valuation estimate

Number of profiles

Profiles5 records

Funding overview

Funding rounds

Investors

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A

Investments

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about Northwest Georgia Oncology Centers